MyFinsight
Home
About
Contact
rare: the income statement
Download
Download image
Net loss
-$180,413K
(-35.12%↓ Y/Y)
Provision for income taxes
$873K
(188.12%↑ Y/Y)
Loss before income
taxes
-$179,540K
(-34.78%↓ Y/Y)
Change in fair value of
equity investments
$678K
(0.00%↑ Y/Y)
Interest income
$5,863K
(-45.36%↓ Y/Y)
Royalty
$64,940K
Product
$94,993K
Other (expense)
income
-$1,043K
(-133.90%↓ Y/Y)
Non-cash interest
expense on liabilities...
$14,148K
(-9.95%↓ Y/Y)
Loss from operations
-$170,890K
(-29.47%↓ Y/Y)
Total revenues
$159,933K
(14.65%↑ Y/Y)
Total operating
expenses
$330,823K
(21.86%↑ Y/Y)
Selling, general and
administrative
$86,620K
(7.80%↑ Y/Y)
Research and development
$216,212K
(27.10%↑ Y/Y)
Cost of sales
$27,991K
(33.16%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)